AAV VECTOR HAVING HIGH AFFINITY WITH NERVOUS SYSTEM, AND APPLICATION THEREOF

The present invention relates to an adeno-associated virus (AAV) capsid protein having a high affinity with a nervous system, an AAV vector comprising the capsid protein, and an application thereof. The AAV capsid protein has a good affinity with tissues and cells of a nervous system, and an AAV vector and drug constructed by using the capsid protein have special advantages in the aspect of treating nervous system diseases..

Medienart:

Patent

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Europäisches Patentamt - (2023) vom: 19. Okt. Zur Gesamtaufnahme - year:2023

Sprache:

Englisch

Beteiligte Personen:

CHENG CHENG [VerfasserIn]
WU XIA [VerfasserIn]
XIAO XIAO [VerfasserIn]
DU ZENGMIN [VerfasserIn]
JIANG WEI [VerfasserIn]
ZHENG JING [VerfasserIn]
CHEN CHEN [VerfasserIn]
ZHAO YANG [VerfasserIn]
WANG TIANYI [VerfasserIn]
WANG HUI [VerfasserIn]

Links:

Volltext [kostenfrei]

Themen:

Sonstige Themen:
615
A61K: Preparations for medical, dental, or toilet purpose (...)
A61P: Specific therapeutic activity of chemical compounds (...)
bio
C07K: Peptides (peptides containing β-lactam rings c07d; (...)
C12N: Microorganisms or enzymes; compositions thereof; pr (...)
che

Anmerkungen:

Source: www.epo.org (no modifications made), First posted: 2023-10-19, Last update posted on www.tib.eu: 2023-11-02, Last updated: 2023-11-10

Patentnummer:

WO2023169115

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

EPA018011853